amyloid modulators (Crossbeta Biosciences)

N/A

Report date: 2025/01/26 19:00:44
NME

Base Information

Drug Nameamyloid modulators (Crossbeta Biosciences)
Drug Alias Nameamyloid modulators (Crossbeta Biosciences)amyloid modulators (Crossbeta Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2AtherosclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossbeta Biosciences BV
China Registration ClassN/A

Develop Information

Active CompaniesCrossbeta Biosciences BV
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsDiabetes Mellitus, Type 2Atherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A